Prospective Observational Study on Outcome of High-precision Hypo-fractionated Radiotherapy in Metastatic Breast Cancer (PRECISE-M)

ConditionsBreast Cancer Metastatic Breast Cancer Radiation Therapy Complication

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexFemale

Age19-100

SponsorSamsung Medical Center

About this trial

This study is a prospective observational study on outcomes of high precision hypo-fractionated radiotherapy in breast cancer with distant metastasis.

Eligibility criteria

Qualifiers

histologically confirmed breast cancer

presence of distant metastasis

radiation therapy using IMRT, SBRT, or proton therapy is done or planned

Able and willing to comply with the study protocol

Disqualifiers

unable to adhere to the study protocol

Trial design

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Sponsors and collaborators

Samsung Medical Center

Lead sponsor

Source ClinicalTrials.gov